基于光栅干涉仪的乳腺X线摄影能否在新鲜活检样本中鉴别良性与恶性微钙化?
前瞻性纳入62例可疑微钙化并接受立体定向活检的患者,用实验性光栅干涉仪乳腺X线摄影测量微钙化的散射与吸收信号比值(R值)。恶性相关微钙化R值均低于4.71,排除高于此阈值的微钙化可使假阳性减少11%,但纤维化与导管原位癌亚组间R值差异未达统计学显著(P=0.07)。
要点
- 恶性相关微钙化R值均低于4.71,可作为潜在鉴别阈值。
- 排除R值高于4.71的微钙化可使假阳性减少11%。
- 纤维化与导管原位癌亚组R值差异未达统计学显著(P=0.07)。
核心结论
- 光栅干涉仪乳腺X线摄影有潜力无创地表征微钙化,并可能有助于在新鲜活检样本中鉴别良性与恶性病变。
研究设计与样本
- 前瞻性、经伦理批准的研究,纳入62例(平均年龄60岁,范围39-89岁)伴可疑微钙化并接受立体定向活检的患者,活检样本用实验性光栅干涉仪装置测量,计算微钙化的散射与吸收信号比值(R值),以最终组织病理学诊断为参考标准。
诊断标准与关键数值
- 62例中20例微钙化与恶性相关;纤维化亚组(n=23)平均R值为4.08,导管原位癌亚组(n=15)平均R值为2.80,P=0.07;所有恶性相关微钙化R值均低于4.71,排除R值高于此阈值的微钙化可使假阳性减少11%。
临床应用与阅片要点
- 作者认为该新型光栅干涉仪模态有潜力无创表征微钙化,并可能有助于在新鲜活检样本中鉴别良性与恶性病变。
局限性
- 纤维化与导管原位癌亚组间R值比较P=0.07,未达统计学显著。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: In addition to absorption imaging, grating interferometry-based mammography (GIM) is capable of detecting differential-phase and scattering signals. In particular, the scattering signal can enable a quantifiable characterization of breast lesions. The purpose of this study was to determine if suspicious microcalcifications associated with benign or malignant lesions can be discriminated based on their absorption and scattering properties.
MATERIALS AND METHODS: In this prospective, ethically approved study, 62 patients (mean age 60 y, range 39-89) with suspicious microcalcifications, who underwent stereotactic biopsies, were included. Biopsies were measured with an experimental GIM device and the ratios of the scattering and absorption signal (R-value) for microcalcifications were calculated. The mean R-values for benign and malignant lesions associated with microcalcifications were compared with the final histopathological diagnosis using a t-test.
RESULTS: Twenty of the 62 participants had microcalcifications associated with malignancy. Comparing the two largest histopathological sub-groups of fibrosis (n = 23) vs. ductal carcinoma in situ (n = 15) resulted in an average R-value of 4.08 for benign and 2.80 for malignant lesions; p = 0.07. All microcalcifications associated with malignancy had an R-value below 4.71. Excluding microcalcifications with an R-value above this threshold would result in an 11 % reduction of false positives.
CONCLUSION: The novel GIM modality has the potential to non-invasively characterize microcalcifications and might aid in the discrimination of benign from malignant lesions in fresh biopsy samples.
引用
- Forte S, Wang Z, Arboleda C, et al. Can grating interferometry-based mammography discriminate benign from malignant microcalcifications in fresh biopsy samples? Eur J Radiol. 2020. PMID: 32446126. doi:10.1016/j.ejrad.2020.109077
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。